Related references
Note: Only part of the references are listed.Inducible Degradation of Oncogenic Nucleolin Using an Aptamer-Based PROTAC
Miao Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2023)
Selective degradation of the p53-R175H oncogenic hotspot mutant by an RNA aptamer-based PROTAC
Lingping Kong et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2023)
Phase 1/2 study of ARV-110, an androgen receptor (AR) PROTAC degrader, in metastatic castration-resistant prostate cancer (mCRPC).
Xin Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
PROTAC targeted protein degraders: the past is prologue
Miklos Bekes et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Development of Chimeric Molecules That Degrade the Estrogen Receptor Using Decoy Oligonucleotide Ligands
Miyako Naganuma et al.
ACS MEDICINAL CHEMISTRY LETTERS (2022)
Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope
Sinan Ma et al.
ACTA PHARMACEUTICA SINICA B (2022)
ARV-471, an estrogen receptor (ER) PROTACdegrader, combined with palbociclib in advanced ER+/human epidermal growth factor receptor 2–negative (HER2-) breast cancer: Phase 1b cohort (part C) of a phase 1/2 study.
Erika P. Hamilton et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor selective degradation of nucleolin
Lin Zhang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
Nucleic-Acid-Based Targeted Degradation in Drug Discovery
Wei Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Insights into the binding mode of AS1411 aptamer to nucleolin
Lihua Bie et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Nanodelivery of nucleic acids
Barbara B. Mendes et al.
NATURE REVIEWS METHODS PRIMERS (2022)
PROTACs: past, present and future
Ke Li et al.
CHEMICAL SOCIETY REVIEWS (2022)
Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications
Shuaijian Ni et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
SELEX-based DNA Aptamer Selection: A Perspective from the Advancement of Separation Techniques
Shingo Saito
ANALYTICAL SCIENCES (2021)
Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges
Shenxin Zeng et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Aptamer-PROTAC Conjugates (APCs) for Tumor-Specific Targeting in Breast Cancer
Shipeng He et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
TF-PROTACs Enable Targeted Degradation of Transcription Factors
Jing Liu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Destruction of DNA-Binding Proteins by Programmable Oligonucleotide PROTAC (O'PROTAC): Effective Targeting of LEF1 and ERG
Jingwei Shao et al.
ADVANCED SCIENCE (2021)
Systematic Evolution of Ligands by Exponential Enrichment Technologies and Aptamer-Based Applications: Recent Progress and Challenges in Precision Medicine of Infectious Diseases
Yixin Xu et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)
Therapeutic applications of AS1411 aptamer, an update review
Rezvan Yazdian-Robati et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
A PROTAC peptide induces durable β-catenin degradation and suppresses Wnt-dependent intestinal cancer
Hongwei Liao et al.
CELL DISCOVERY (2020)
A cell-permeable peptide-based PROTAC against the oncoprotein CREPT proficiently inhibits pancreatic cancer
Danhui Ma et al.
THERANOSTICS (2020)
Recent Advances in Aptamer Discovery and Applications
Yang Zhang et al.
MOLECULES (2019)
First targeted protein degrader hits the clinic
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2019)
Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells
Josue Carvalho et al.
SCIENTIFIC REPORTS (2019)
Aptamer chemistry
Pascal Rothlisberger et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor degradation
Nobumichi Ohoka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine
Zhenjian Zhuo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs)
Nobumichi Ohoka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
DNA aptamer probes for detection of estrogen receptor α positive carcinomas
Arghya Sett et al.
TRANSLATIONAL RESEARCH (2017)
Posttranslational protein knockdown coupled to receptor tyrosine kinase activation with phosphoPROTACs
John Hines et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Identification of RNA Aptamer Specific to Mutant KRAS Protein
Sujin Jeong et al.
OLIGONUCLEOTIDES (2010)